Literature DB >> 26940685

Pembrolizumab-induced necrotic myositis in a patient with metastatic melanoma.

H Vallet1, A Gaillet2, N Weiss3, C Vanhaecke4, S Saheb5, V Touitou6, N Franck4, N Kramkimel4, A Borden7, M Touat8, D Ricard9, M Verny1, T Maisonobe10, D Psimaras11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26940685     DOI： 10.1093/annonc/mdw126

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  15 in total

1.  Neurological Complications Associated With Anti-Programmed Death 1 (PD-1) Antibodies.

Authors:  Justin C Kao; Bing Liao; Svetomir N Markovic; Christopher J Klein; Elie Naddaf; Nathan P Staff; Teerin Liewluck; Julie E Hammack; Paola Sandroni; Heidi Finnes; Michelle L Mauermann
Journal:  JAMA Neurol       Date:  2017-10-01       Impact factor: 18.302

Review 2.  Immune Checkpoint Inhibitor-Induced Myositis: a Case Report and Literature Review.

Authors:  Hiroko Kadota; Takahisa Gono; Yuichiro Shirai; Yuka Okazaki; Mitsuhiro Takeno; Masataka Kuwana
Journal:  Curr Rheumatol Rep       Date:  2019-02-21       Impact factor: 4.592

Review 3.  Neurological Adverse Events Associated with Immune Checkpoint Inhibitors: Diagnosis and Management.

Authors:  Christophoros Astaras; Rita de Micheli; Bianca Moura; Thomas Hundsberger; Andreas F Hottinger
Journal:  Curr Neurol Neurosci Rep       Date:  2018-02-01       Impact factor: 5.081

Review 4.  Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors.

Authors:  Justin C Kao; Adipong Brickshawana; Teerin Liewluck
Journal:  Curr Neurol Neurosci Rep       Date:  2018-08-04       Impact factor: 5.081

Review 5.  Autoimmune Myopathies: Updates on Evaluation and Treatment.

Authors:  Emer R McGrath; Christopher T Doughty; Anthony A Amato
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

6.  Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer.

Authors:  So Young Huh; Seong Hoon Shin; Meyung Kug Kim; So Young Lee; Ki Hun Son; Ha Young Shin
Journal:  J Clin Neurol       Date:  2018-01       Impact factor: 3.077

7.  Pembrolizumab induced bulbar myopathy and respiratory failure with necrotizing myositis of the diaphragm.

Authors:  C L Haddox; N Shenoy; K K Shah; J C Kao; S Jain; T R Halfdanarson; E F Wijdicks; M P Goetz
Journal:  Ann Oncol       Date:  2017-03-01       Impact factor: 32.976

Review 8.  Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature.

Authors:  Devis Benfaremo; Lucia Manfredi; Michele Maria Luchetti; Armando Gabrielli
Journal:  Curr Drug Saf       Date:  2018

Review 9.  Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors.

Authors:  Yan Xiao; Lin Zeng; Qinglin Shen; Zhiyong Zhou; Zhifang Mao; Qin Wang; Xiquan Zhang; Yingliang Li; Weirong Yao
Journal:  J Immunol Res       Date:  2020-08-04       Impact factor: 4.818

10.  Brachial Plexus Neuritis Associated With Anti-Programmed Cell Death-1 Antibodies: Report of 2 Cases.

Authors:  Reem M Alhammad; Roxanna S Dronca; Lisa A Kottschade; Heidi J Turner; Nathan P Staff; Michelle L Mauermann; Jennifer A Tracy; Christopher J Klein
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.